Maria Emilsson

Dr. Maria Emilsson

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2009 in Respiratory Medicine
Verified
Journal Article
Closed access
MAM. Axelsson
M. Axelsson
MEMaria Emilsson
Maria Emilsson
EBE. Brink
E. Brink
JLJ. Lundgren
J. Lundgren
KTK. Torén
K. Torén
JLJan Olof Lötvall
Jan Olof Lötvall

10 February 2011 in Primary Care Respiratory Journal
Verified
Journal Article
Closed access
PDF file
MEMaria Emilsson
Maria Emilsson
IBIna Berndtsson
Ina Berndtsson
JLJan Olof Lötvall
Jan Olof Lötvall
EMEva Millqvist
Eva Millqvist
JLJesper Lundgren
Jesper Lundgren
EBEva Brink
Eva Brink

15 November 2016 in European Child & Adolescent Psychiatry
Verified
Journal Article
Open access
PDF file
MEMaria Emilsson
Maria Emilsson
PGPer A. Gustafsson
Per A. Gustafsson
GÖGisela Öhnström
Gisela Öhnström
IMIna Marteinsdottir
Ina Marteinsdottir
Adherence to attention deficit hyperactivity disorder (ADHD) treatment is important because, when untreated, it may have serious consequences with lifelong effects. In the case of adolescents on long-term medicine prescription, more knowledge is needed regarding adherence and factors influencing adherence, which was the purpose of this study. Adolescents (n = 101) on ADHD medication ≥6 months were administrated questionnaires at a monitoring appointment: Medication Adherence Report Scale (MARS), beliefs about medicines (BMQ) and the Brief Illness Perception Questionnaire (B-IPQ). Adherence was high, the mean value was 88% of the maximum MARS score, and correlated positively with the “BMQ-necessity-concerns differential” but negatively with “BMQ-concerns” and “BMQ-side effects”. Adolescents with more belief in the necessity of the medication, less concerns and less experience of side effects tended to be more adherent to medication prescription (“intentional non-adherence”), while “unintentional non-adherence” (forgetfulness) was associated with how much they perceived that their ADHD affected their lives. In a multiple regression model, the variance of MARS total (R 2 = 0.21) and “intentional non-adherence” (R 2 = 0.24) was explained by the “BMQ-necessity–concern differential” and “BMQ-experienced side effects”. The variance of “unintentional non-adherence” (R 2 = 0.12) was explained by the “BMQ-necessity–concern differential” and “B-IPQ-consequences of ADHD”. In conclusion, adolescents on long-term medication reported good adherence, mainly influenced by more beliefs in the necessity versus concerns of the medications, less experienced side effects and more perceived consequences of ADHD. BMQ could be useful to identify risks of low adherence, which should be counteracted by partially gender-specific interventions.

30 March 2020 in BMC Psychiatry
Verified
Journal Article
Open access
PDF file
MEMaria Emilsson
Maria Emilsson
PGPer Gustafsson
Per Gustafsson
GÖGisela Öhnström
Gisela Öhnström
IMIna Marteinsdottir
Ina Marteinsdottir
Background: Adherence to attention deficit hyperactivity disorder (ADHD) medication can prevent serious consequences, possibly with lifelong effects. Numerous factors have been observed that influence adherent behaviour, but the impact of personality traits has been inadequately explored. The purpose of this study was to explore the associations between personality traits and adherence to ADHD medication, beliefs about the medication, and perceptions of ADHD.Method: Adolescents (n = 99) on ADHD medication were administered: Health-Relevant Personality Traits Five-Factor Inventory, Medication Adherence Report Scale, Beliefs about Medicines Specific and Brief Illness Perceptions Questionnaires.Results: The personality trait Antagonism correlated with adherence behaviour (r = − 0.198,p = 0.005) and perceived personal control of ADHD (r = − 0.269,p = 0.007). Negative Affectivity correlated with beliefs regarding necessity (r = 0.319,p = 0.001), concerns (r = 0.344,p = 0.001), and experienced side effects of medication (r = 0.495,p = 0.001), alongside perceptions regarding duration (r = 0.272,p = 0.007), identity (r = 0.388,p < 0.001), being emotionally affected (r = 0.374,p < 0.01), personal control (r = − 0.287,p = 0.004) and concerns about ADHD (r = 0.465,p < 0.001). Impulsivity correlated with perceived consequences (r = − 0.226,p = 0.0255) and personal control of ADHD (r = − 0.379,p < 0.001). Hedonic Capacity correlated with concerns about medication (r = − 0.218,p = 0.0316) and perceived identification with ADHD (r = − 0.203,p = 0.045).Conclusion: Personality traits are related to adherence, beliefs about ADHD medicines and perceptions of ADHD. Antagonism is associated with adherence, especially intentional non-adherence, while Negative Affectivity correlates with numerous perceptions of ADHD and beliefs about medications. Personality assessments could be useful in the care and treatment of adolescents with ADHD.

7 August 2020 in Sustainability
Verified
Journal Article
Open access
PDF file
MEMaria Emilsson
Maria Emilsson
UEUlf Ernstson
Ulf Ernstson
LGLinn Gustavsson
Linn Gustavsson
Ann SvenssonAnn Svensson
Ann Svensson
Small enterprises face multiple and complex challenges when developing digital technologies. The aim of this article is to explore the role of sustainable innovation in small enterprises in relation to the ongoing transformation of the primary healthcare sector. The purpose is to gain understanding of innovation processes within the framework of sustainable development, applied to a local primary healthcare center. Data were collected through seven semi-structured interviews. A qualitative thematic analysis was conducted. Five themes appeared in relation to the ongoing transformation of the primary healthcare sector: (1) The process of sustainable innovation in a long-term perspective; (2) the companies’ views on innovations in healthcare; (3) effects of innovations in healthcare; (4) sustainable product or service development, and (5) the role of collaboration in the innovation process. The companies expressed a positive attitude to new innovations, as a natural part of developing the companies. The article concludes that incremental development of tools in small businesses supports the transformation of processes and services in the primary healthcare sector. Cross-disciplinary teams in collaboration facilitates the necessary learning and the required creation and sharing of knowledge.

9 October 2019 in Nordic Journal of Psychiatry
Verified
Journal Article
Open access
MEMaria Emilsson
Maria Emilsson
IBIna Berndtsson
Ina Berndtsson
PGPer A. Gustafsson
Per A. Gustafsson
RHRobert Horne
Robert Horne
IMIna Marteinsdottir
Ina Marteinsdottir
Objectives: The purpose of this study was to assess the reliability and validity of Swedish translations of the Beliefs about Medicines Questionnaire-Specific (BMQ-Specific) and Brief Illness Perception Questionnaire (B-IPQ) for use in adolescents with ADHD. Methods: Forward and backward translations of the BMQ-Specific and B-IPQ scales to Swedish were conducted and reviewed by adolescents with ADHD and professionals. The validity and reliability of both questionnaires were investigated in a cross-sectional study of 101 adolescents (13–17 years) on a long-term prescription of ADHD medication recruited from two child and adolescent psychiatric outpatient clinics in Sweden. Results: Regarding the BMQ-Specific, principal component analysis (PCA) loadings confirmed the previously defined components of Specific-Necessity and Specific-Concern. The PCA for B-IPQ revealed two components, the first one, B-IPQ Consequences, captured questions regarding perceptions of the implication of having ADHD (items 1, 2, 5, 6 and 8) and the second one, B-IPQ-Control, the perceptions of the capability to manage the ADHD disorder (items 3, 4 and 7). The Cronbach alpha coefficients for BMQ-Specific-Necessity scale was α = 0.80, for BMQ-Specific-Concern scale α = 0.75, B-IPQ Consequences α = 0.74 and for B-IPQ-Control α = 0.44. Conclusions: The present results prove the Swedish translation of BMQ-Specific and B-IPQ to be valid and reliable for utilization in adolescents with ADHD. The PCA confirmed the original components for BMQ-Specific and the recent findings of two main B-IPQ components describing emotional and cognitive implications versus the capability for self-care maintenance of ADHD.